CI
MRNA icon

Cordant Inc’s Moderna MRNA Stock Holding History

Cordant Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$701 Buy
+10
New +$517 ﹤0.01% 171
2022
Q2 		– Sell
-21
Closed -$4K – 806
2022
Q1 		$4K Buy
+21
New +$3.54K ﹤0.01% 368
2021
Q4 		– Sell
-3
Closed -$1K – 253
2021
Q3 		$1K Buy
+3
New +$1.11K ﹤0.01% 285
2021
Q1 		– Sell
-3
Closed – – 91
2020
Q4 		$0 Hold
3
– – ﹤0.01% 58
2020
Q3 		$0 Buy
+3
New +$209 ﹤0.01% 69

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
RA
REX Advisers Fairfield, Connecticut $44.3M AUM

Cordant Inc's MRNA Position: Q2 2026 in Review

Cordant Inc opened a new position in Moderna (MRNA) in Q2 2026: 10 shares worth $701. The stake represents ﹤0.01% of the portfolio and ranks #171 among its holdings. This is a return to the name: Cordant Inc previously reported a position in MRNA as recently as Q1 2022.

Cordant Inc first reported a position in MRNA in Q3 2020 and has held it in 5 quarters since. The position peaked at $4K in Q1 2022. 99 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Cordant Inc held 10 shares of Moderna worth $701 as of Q2 2026.
  • Moderna was a new Cordant Inc position in Q2 2026.
  • Moderna made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #171 holding.
  • Cordant Inc first reported a position in Moderna in Q3 2020 and has held it in 5 quarters since.
  • Cordant Inc's Moderna position peaked at $4K in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.